Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

OBJECTIVES: To evaluate the discrimination, calibration, and net benefit performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) across five European randomized study of screening for prostate cancer (ERSPC), 1 United Kingdom, 1 Austrian, and 3 US biopsy cohorts. METHODS: PCPTRC...

Full description

Bibliographic Details
Main Authors:	Ankerst, D, Boeck, A, Freedland, S, Thompson, I, Cronin, A, Roobol, M, Hugosson, J, Stephen Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Moreira, D, Schröder, F, Lilja, H, Vickers, A
Format:	Journal article
Language:	English
Published:	2012

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Similar Items